Brainsway Ltd. Sponsored ADR

BWAY Healthcare Medical Devices

Brainsway Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $52.2 million, up 27.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.4%, EPS grew 40.0% and free cash flow fell 51.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

11.41 0.41 −3.47%
Market cap
$475.8M
P/E
24.8×
Fwd P/E
0.0×
Dividend yield
—
F-score
6/9
Altman Z
2.82
Beneish M
−2.45
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
33.72 31.64 26.42 31.42

+8 more quarters

P/S ratio
4.95 4.51 3.46 6.01
P/FCF ratio
51.89 21.90 11.93 16.09
P/Operating CF
47.62 216.58 (139.98) 212.98
P/B ratio
3.79 3.35 2.47 4.21
EV/Sales
3.95 3.49 2.19 4.61
EV/EBITDA
25.97 26.69 19.48 47.82
EV/FCF
41.42 16.96 7.54 12.34
Current Ratio
3.59 3.34 3.73 3.19
Net Debt/EBITDA
(22.39) (24.30) (30.59) (43.32)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
2.97% 3.16% 3.79% 3.18%
Free Cash Flow Yield
1.93% 4.57% 8.38% 6.21%
Free Cash Flow per Share
0.28 0.02 (0.03) 0.02
Book value per Share
4.09 3.97 3.85 1.79
Free Cash Flow
5.42 0.40 (0.62) 0.59
EV/EBIT
31.68 34.15 26.42 79.73
Other line items

Show all line items

Columns are period end dates